Examining Association of Personality Characteristics and Neuropsychiatric Symptoms in Post-COVID Syndrome.
COVID-19
cognitive
depression
personality
post-COVID syndrome
Journal
Brain sciences
ISSN: 2076-3425
Titre abrégé: Brain Sci
Pays: Switzerland
ID NLM: 101598646
Informations de publication
Date de publication:
14 Feb 2022
14 Feb 2022
Historique:
received:
04
01
2022
revised:
10
02
2022
accepted:
10
02
2022
entrez:
25
2
2022
pubmed:
26
2
2022
medline:
26
2
2022
Statut:
epublish
Résumé
We aimed to evaluate personality traits in patients with post-COVID syndrome, as well as the association with neuropsychiatric symptoms present in this disorder. The Big Five Structure Inventory was administered to 93 consecutive patients with a diagnosis of post-COVID syndrome as defined by the WHO and to demographically matched controls. We also performed a comprehensive evaluation of depression, anxiety, fatigue, sleep quality, cognitive function, and olfactory function. Patients with post-COVID syndrome scored lower for emotional stability, equanimity, positive mood, and self-control. Extraversion, emotional stability, and openness correlated negatively with anxiety and depression levels. Conscientiousness correlated negatively with anxiety. No statistically significant correlations were observed between personality traits and cognitive function, sleep quality, olfactory function, or fatigue. Personality scores explained 36.3% and 41% of the variance in scores on the anxiety and depression scales, respectively. Two personality profiles with lower levels of emotional stability were associated with depression and anxiety. Our study shows higher levels of neuroticism in patients with post-COVID syndrome. Personality traits were predictive of the presence of depression and anxiety, but not cognitive function, sleep quality, or fatigue, in the context of post-COVID syndrome. These findings may have implications for the detection of patients at risk of depression and anxiety in post-COVID syndrome, and for the development of preventive and therapeutic interventions.
Sections du résumé
BACKGROUND
BACKGROUND
We aimed to evaluate personality traits in patients with post-COVID syndrome, as well as the association with neuropsychiatric symptoms present in this disorder.
METHODS
METHODS
The Big Five Structure Inventory was administered to 93 consecutive patients with a diagnosis of post-COVID syndrome as defined by the WHO and to demographically matched controls. We also performed a comprehensive evaluation of depression, anxiety, fatigue, sleep quality, cognitive function, and olfactory function.
RESULTS
RESULTS
Patients with post-COVID syndrome scored lower for emotional stability, equanimity, positive mood, and self-control. Extraversion, emotional stability, and openness correlated negatively with anxiety and depression levels. Conscientiousness correlated negatively with anxiety. No statistically significant correlations were observed between personality traits and cognitive function, sleep quality, olfactory function, or fatigue. Personality scores explained 36.3% and 41% of the variance in scores on the anxiety and depression scales, respectively. Two personality profiles with lower levels of emotional stability were associated with depression and anxiety.
CONCLUSIONS
CONCLUSIONS
Our study shows higher levels of neuroticism in patients with post-COVID syndrome. Personality traits were predictive of the presence of depression and anxiety, but not cognitive function, sleep quality, or fatigue, in the context of post-COVID syndrome. These findings may have implications for the detection of patients at risk of depression and anxiety in post-COVID syndrome, and for the development of preventive and therapeutic interventions.
Identifiants
pubmed: 35204028
pii: brainsci12020265
doi: 10.3390/brainsci12020265
pmc: PMC8870488
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Comunidad de Madrid
ID : FIBHCSC 2020 COVID-19
Organisme : Instituto de Salud Carlos III
ID : INT20/00079
Organisme : Instituto de Salud Carlos III
ID : FI20/000145
Références
Vaccines (Basel). 2021 May 12;9(5):
pubmed: 34066007
J Alzheimers Dis. 2019;71(4):1153-1162
pubmed: 31524166
J Affect Disord. 2021 Jun 1;288:175-188
pubmed: 33901698
Mult Scler. 2005 Feb;11(1):76-80
pubmed: 15732270
J Pain Res. 2020 Apr 14;13:745-754
pubmed: 32346307
J Psychosom Res. 2003 Mar;54(3):271-8
pubmed: 12614837
Clin J Pain. 2017 Nov;33(11):991-997
pubmed: 28448425
Mov Disord. 2020 Jul;35(7):1104-1105
pubmed: 32502296
Proc Natl Acad Sci U S A. 2021 Sep 14;118(37):
pubmed: 34508007
Health Psychol. 2007 Jul;26(4):473-80
pubmed: 17605567
J Am Geriatr Soc. 2020 Jul;68(7):1554-1559
pubmed: 32488931
Rev Neurol (Paris). 2022 Jan-Feb;178(1-2):137-143
pubmed: 35000793
Sci Rep. 2021 Aug 9;11(1):16144
pubmed: 34373540
Trends Psychiatry Psychother. 2020 Jun;42(2):179-184
pubmed: 32294713
Scand J Pain. 2017 Oct;17:58-67
pubmed: 28850375
Am J Alzheimers Dis Other Demen. 2013 Dec;28(8):776-83
pubmed: 24363073
Health Qual Life Outcomes. 2018 May 24;16(1):101
pubmed: 29793544
J Alzheimers Dis. 2018;63(4):1523-1535
pubmed: 29782316
Ann Clin Transl Neurol. 2022 Feb;9(2):221-226
pubmed: 35043593
J Clin Psychiatry. 2009 Jun;70(6):817-28
pubmed: 19573480
Aging Health Res. 2021 Dec;1(4):100038
pubmed: 34568860
Front Psychol. 2021 Nov 04;12:724022
pubmed: 34803804
Science. 2022 Jan 21;375(6578):267-269
pubmed: 35050660
J Affect Disord. 2021 Jan 15;279:578-584
pubmed: 33152562
Arch Clin Neuropsychol. 2022 Feb 05;:
pubmed: 35136912
Nat Hum Behav. 2018 Oct;2(10):735-742
pubmed: 31406291
Appl Neuropsychol Adult. 2021 Jun 24;:1-10
pubmed: 34167406
J Neurol Sci. 2022 Jan 29;434:120162
pubmed: 35121209
Psychol Bull. 2000 Jan;126(1):3-25
pubmed: 10668348
Aging Ment Health. 2020 Nov;24(11):1935-1944
pubmed: 31561724
J Psychiatr Res. 2017 Jun;89:22-27
pubmed: 28153642
PLoS One. 2021 May 19;16(5):e0251984
pubmed: 34010358